Maker of Neuromodulator to Treat Heart Failure, CVRx, Raises $46M

According to Med City News, “Minneapolis’ CVRx has raised $46 million from unnamed investors in support of its implantable neuromodulator to treat high blood pressure and heart failure, bringing its total equity funding to $237 million over 5 rounds.”  For...

GSK Wants to Replace Drugs with Tiny Implants

“GlaxoSmithKline (GSK) has developed a division devoted entirely to bioelectronics that can be attached to nerves to regulate drugs, or even eliminate the need for them.  GSK is seen as a pioneer in this space, and is partially funding development of...